Insulin, C-peptide, adiponectin, and C-reactive protein (CRP) were selected to capture participants’ overall insulin sensitivity and inflammation profiles before and after the intervention, and serum PSA changes were investigated as a marker of tumor progression [11, 14]. This evidence concerns the gene INS and neoplasm.